Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C. Becker

Showing results (61-70 of 329) with videos related to

Pageof 33
Sort By:
American Heart Journal|October 12, 2010
Dronedarone and vitamin K antagonists: a review of drug-drug interactionsShailesh C Shirolkar, Mona Fiuzat, Richard C Becker
Circulation Research|February 9, 2018
Translational Implications of Platelets as Vascular First RespondersRichard C Becker, Travis Sexton, Susan S Smyth
Journal of Thrombosis and Thrombolysis|January 4, 2020
Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathyRichard C Becker, A Phillip Owens, Sakthivel Sadayappan
Revista Espanola De Cardiologia|June 7, 2011
[Hematologic diseases: from within the heart]Weixian Xu, Tracy Y Wang, Richard C Becker
Journal of Thrombosis and Thrombolysis|March 16, 2011
The many faces of the contact pathway and their role in thrombosisRebecca S Woodruff, Bruce Sullenger, Richard C Becker
Cancers|January 5, 2021
Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac ToxicityMohit Kumar, Chellappagounder Thangavel, Richard C Becker, et al.
Neurosurgery Clinics of North America|September 19, 2018
Anticoagulants: Pharmacokinetics, Mechanisms of Action, and IndicationsTracy A DeWald, Jeffrey B Washam, Richard C Becker
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
The American Journal of Medicine|January 12, 2008
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysisJeffrey S Berger, David L Brown, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
Pageof 33

Showing results (61-70 of 329) with videos related to

Sort By:
Pageof 33
American Heart Journal|October 12, 2010
Dronedarone and vitamin K antagonists: a review of drug-drug interactionsShailesh C Shirolkar, Mona Fiuzat, Richard C Becker
Circulation Research|February 9, 2018
Translational Implications of Platelets as Vascular First RespondersRichard C Becker, Travis Sexton, Susan S Smyth
Journal of Thrombosis and Thrombolysis|January 4, 2020
Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathyRichard C Becker, A Phillip Owens, Sakthivel Sadayappan
Revista Espanola De Cardiologia|June 7, 2011
[Hematologic diseases: from within the heart]Weixian Xu, Tracy Y Wang, Richard C Becker
Journal of Thrombosis and Thrombolysis|March 16, 2011
The many faces of the contact pathway and their role in thrombosisRebecca S Woodruff, Bruce Sullenger, Richard C Becker
Cancers|January 5, 2021
Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac ToxicityMohit Kumar, Chellappagounder Thangavel, Richard C Becker, et al.
Neurosurgery Clinics of North America|September 19, 2018
Anticoagulants: Pharmacokinetics, Mechanisms of Action, and IndicationsTracy A DeWald, Jeffrey B Washam, Richard C Becker
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
The American Journal of Medicine|January 12, 2008
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysisJeffrey S Berger, David L Brown, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
Pageof 33